MKMERCK Kommanditgesellschaft auf Aktien MKKGY · OTC
$33.68 +0.03% (+$0.01)
- Market cap
- 65.4B €
- Enterprise value
- 75.8B €
- P/E
- 27.6x
- Forward P/E
- 17.4x
- PEG
- -
- P/S
- 3.1x
- P/FCF
- 25.8x
- EV/EBITDA
- 11.5x
- ROIC
- 7.1%
- Gross margin
- 58.7%
- Net margin
- 11.2%
- Dividend yield
- 1.53%
- Payout ratio
- 42.1%
- Net debt/EBITDA
- 1.6x
- Beta
- 0.81
- Free float
- 5.9%
About the company
MERCK Kommanditgesellschaft auf Aktien (known as Merck Group) is a German multinational company founded in 1668, specializing in science and technology. The company focuses on biotechnology, pharmaceuticals, chemicals, and materials science. Merck is known for its innovations in healthcare, such as new drugs and therapies, as well as in scientific tools and laboratory products. The company has a global presence and operates in many markets, providing solutions for healthcare, scientific research, and industrial manufacturing.
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Kai Beckmann
Employees
62,461
Headquarters
Darmstadt
Valuation
Is today's price reasonable?
- What to watch: The share price is above the Bulios Fair Price.
Growth and estimates
Is it growing, and what comes next?
- What to watch: Revenue fell by 3.0% a year over the last 3 years.
Profitability and quality
How much of the revenue is left, and how well does the company use its capital?
- What speaks for it: Out of every 100 EUR of revenue, 11 EUR is left as net profit.
Financial health
Can it carry its debt?
Capital and dividends
What does the company do with the money it earns?
- What speaks for it: It has raised its dividend 5 years in a row and pays out only 42% of profit.
Analysts
What do the professionals think, and is it changing?
Owners and insiders
Who holds the stock, and what is management doing?
Segments
Which part of the company is growing?
Peer comparison
How does it compare with similar companies?
Price and risk
How does the stock behave?
Statements
Every number